BioNTech's Q2 revenues double on higher COVID vaccine sales
Go back to BioNTech's Q2 revenues double on higher COVID vaccine sales| (NASDAQ: BNTX) | Delayed: 102.08 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.08 | 52 Week High | $ | |||
| Open | $102.08 | 52 Week Low | $ | |||
| Day High | $102.08 | P/E | N/A | |||
| Day Low | $102.08 | EPS | $ | |||
| Volume | 4,409 | |||||

